Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 25, 2019

SELL
$126.95 - $142.14 $32.9 Million - $36.8 Million
-259,139 Closed
0 $0
Q2 2019

Jul 26, 2019

SELL
$131.15 - $144.24 $986,248 - $1.08 Million
-7,520 Reduced 2.82%
259,139 $36.1 Million
Q1 2019

May 09, 2019

SELL
$125.72 - $139.79 $1.02 Million - $1.14 Million
-8,132 Reduced 2.96%
266,659 $37.3 Million
Q4 2018

Feb 04, 2019

SELL
$122.84 - $147.84 $1.5 Million - $1.81 Million
-12,221 Reduced 4.26%
274,791 $35.5 Million
Q3 2018

Oct 23, 2018

SELL
$121.58 - $142.88 $877,807 - $1.03 Million
-7,220 Reduced 2.45%
287,012 $39.7 Million
Q2 2018

Jul 24, 2018

SELL
$119.4 - $131.76 $628,760 - $693,848
-5,266 Reduced 1.76%
294,232 $35.7 Million
Q1 2018

May 04, 2018

SELL
$125.1 - $148.14 $13,010 - $15,406
-104 Reduced 0.03%
299,498 $38.4 Million
Q4 2017

Feb 13, 2018

SELL
$131.22 - $143.62 $1.84 Million - $2.01 Million
-14,013 Reduced 4.47%
299,602 $41.9 Million
Q3 2017

Nov 06, 2017

BUY
$129.47 - $135.38 $40.6 Million - $42.5 Million
313,615
313,615 $40.8 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $382B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Smead Capital Management, Inc. Portfolio

Follow Smead Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smead Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Smead Capital Management, Inc. with notifications on news.